Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02642263
Other study ID # Uterotonic Carbetocin
Secondary ID
Status Not yet recruiting
Phase Phase 4
First received
Last updated
Start date February 1, 2019
Est. completion date January 2022

Study information

Verified date May 2018
Source University Hospital Inselspital, Berne
Contact Pascal H Vuilleumier, MD
Phone +41 31 632 21 11
Email pascal.vuilleumier@insel.ch
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Carbetocin is an oxytocin agonist used for prevention of postpartum bleeding after cesarean delivery. First studies revealed in 2012 an analgesic effect of carbetocin, compared to its parent substance oxytocin. This study will enroll 78 women undergoing cesarean delivery. In a double-blind, prospective design patients will be either attributed to the oxytocin or the carbetocin study arm. The primary endpoint will be the area of hyperalgesia around the cesarean delivery scar. This will be performed with a von Frey hair, resulting in a unpleasant feeling in the area of hyperalgesia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 78
Est. completion date January 2022
Est. primary completion date December 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Age 18-45, uneventful pregnancy, on term (>37 0/7 weeks of gestation), scheduled elective CS including repeat CS

Exclusion Criteria:

- lack of informed consent, active labor, multiple pregnancy, polyhydramnios, severe fetal malformations

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Carbetocin
Postpartum uterotonic drug

Locations

Country Name City State
Switzerland Dep. of Anesthesiology and Pain Medicine, Bern University Hospital Bern

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cesarean delivery scar cutaneous hyperalgesia In the area of the cesarean delivery scar, the area of dynamic secondary hyperalgesia for punctate mechanical stimuli around the surgical incision will be measured around her scar according to the method described by Stubhaug et al. In brief, stimulation with a Von Frey Filament (225.1gr) is started from outside the hyperalgesic area where no pain sensation is experienced toward the incision until the patient reports a distinct change in perception. The first point where a painful, sore, or sharp feeling appears is recorded, and the distance to the incision is measured. If no change in sensation appears, stimulation is stopped at 0.5 cm from the incision. The area of secondary hyperalgesia is determined by testing along radial lines separated by 5 cm around the incision. The observations are translated onto graph paper, and the surface is calculated as cm2/cm of incision. 4 hours after cesarean delivery
Secondary Pressure pain detection threshold Pain detection thresholds will be measured with an electronic pressure algometer (Algometer, Somedic, Denmark) applied at the center of the pulp of the 2nd toe. The probe has a surface area of 1 cm2. The pressure is increased from 0 at a rate of 30kPa/s to a maximum pressure of 1000kPa. Pain detection threshold is defined as the point at which the pressure sensation turns to pain. The subjects are instructed to press a button when these points are reached. The algometer displays the pressure intensity at which the button is pressed. If the subjects do not press the button at a pressure of 1000 kPa, this value is considered as threshold. before cesarean
Secondary Pressure pain detection threshold Pain detection thresholds will be measured with an electronic pressure algometer (Algometer, Somedic, Denmark) applied at the center of the pulp of the 2nd toe. The probe has a surface area of 1 cm2. The pressure is increased from 0 at a rate of 30kPa/s to a maximum pressure of 1000kPa. Pain detection threshold is defined as the point at which the pressure sensation turns to pain. The subjects are instructed to press a button when these points are reached. The algometer displays the pressure intensity at which the button is pressed. If the subjects do not press the button at a pressure of 1000 kPa, this value is considered as threshold. 4 hours after cesarean
Secondary Pressure pain detection threshold Pain detection thresholds will be measured with an electronic pressure algometer (Algometer, Somedic, Denmark) applied at the center of the pulp of the 2nd toe. The probe has a surface area of 1 cm2. The pressure is increased from 0 at a rate of 30kPa/s to a maximum pressure of 1000kPa. Pain detection threshold is defined as the point at which the pressure sensation turns to pain. The subjects are instructed to press a button when these points are reached. The algometer displays the pressure intensity at which the button is pressed. If the subjects do not press the button at a pressure of 1000 kPa, this value is considered as threshold. 24 hours after cesarean
Secondary Pressure pain detection threshold Pain detection thresholds will be measured with an electronic pressure algometer (Algometer, Somedic, Denmark) applied at the center of the pulp of the 2nd toe. The probe has a surface area of 1 cm2. The pressure is increased from 0 at a rate of 30kPa/s to a maximum pressure of 1000kPa. Pain detection threshold is defined as the point at which the pressure sensation turns to pain. The subjects are instructed to press a button when these points are reached. The algometer displays the pressure intensity at which the button is pressed. If the subjects do not press the button at a pressure of 1000 kPa, this value is considered as threshold. 48 hours after cesarean
Secondary Pressure pain detection threshold Pain detection thresholds will be measured with an electronic pressure algometer (Algometer, Somedic, Denmark) applied at the center of the pulp of the 2nd toe. The probe has a surface area of 1 cm2. The pressure is increased from 0 at a rate of 30kPa/s to a maximum pressure of 1000kPa. Pain detection threshold is defined as the point at which the pressure sensation turns to pain. The subjects are instructed to press a button when these points are reached. The algometer displays the pressure intensity at which the button is pressed. If the subjects do not press the button at a pressure of 1000 kPa, this value is considered as threshold. 6 weeks after cesarean
Secondary Baseline depression detection Beck Depression Inventory (BDI-II): a 21 question multiple choice inventory used to measure severity of depression. This will be used in order to assess an eventual prepartum depression, this measure aims at eliminating bias if detecting a postpartum depression by the Edinburgh Depression questionnaire before cesarean
Secondary Postpartum depression Assessment of postpartum depression with the Edinburgh Postnatal Depression Scale. It is a 10 item questionnaire. 6 weeks post cesarean
Secondary Cesarean delivery scar cutaneous hyperalgesia In the area of the cesarean delivery scar, the area of dynamic secondary hyperalgesia for punctate mechanical stimuli around the surgical incision will be measured around her scar according to the method described by Stubhaug et al. In brief, stimulation with a Von Frey Filament (225.1gr) is started from outside the hyperalgesic area where no pain sensation is experienced toward the incision until the patient reports a distinct change in perception. The first point where a painful, sore, or sharp feeling appears is recorded, and the distance to the incision is measured. If no change in sensation appears, stimulation is stopped at 0.5 cm from the incision. The area of secondary hyperalgesia is determined by testing along radial lines separated by 5 cm around the incision. The observations are translated onto graph paper, and the surface is calculated as cm2/cm of incision. 24 hours after cesarean
Secondary Cesarean delivery scar cutaneous hyperalgesia In the area of the cesarean delivery scar, the area of dynamic secondary hyperalgesia for punctate mechanical stimuli around the surgical incision will be measured around her scar according to the method described by Stubhaug et al. In brief, stimulation with a Von Frey Filament (225.1gr) is started from outside the hyperalgesic area where no pain sensation is experienced toward the incision until the patient reports a distinct change in perception. The first point where a painful, sore, or sharp feeling appears is recorded, and the distance to the incision is measured. If no change in sensation appears, stimulation is stopped at 0.5 cm from the incision. The area of secondary hyperalgesia is determined by testing along radial lines separated by 5 cm around the incision. The observations are translated onto graph paper, and the surface is calculated as cm2/cm of incision. 48 hours after cesarean
Secondary Cesarean delivery scar cutaneous hyperalgesia In the area of the cesarean delivery scar, the area of dynamic secondary hyperalgesia for punctate mechanical stimuli around the surgical incision will be measured around her scar according to the method described by Stubhaug et al. In brief, stimulation with a Von Frey Filament (225.1gr) is started from outside the hyperalgesic area where no pain sensation is experienced toward the incision until the patient reports a distinct change in perception. The first point where a painful, sore, or sharp feeling appears is recorded, and the distance to the incision is measured. If no change in sensation appears, stimulation is stopped at 0.5 cm from the incision. The area of secondary hyperalgesia is determined by testing along radial lines separated by 5 cm around the incision. The observations are translated onto graph paper, and the surface is calculated as cm2/cm of incision. 6 weeks after cesarean
See also
  Status Clinical Trial Phase
Completed NCT03236324 - Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery Phase 2
Recruiting NCT04058444 - The First ERAS Protocol for Cesarean Delivery in Serbia at the University Hospital N/A
Completed NCT03150641 - Delayed Cord Clamping at Term Cesarean N/A
Recruiting NCT06247852 - Persistent Pain After Cesarean Delivery - A Danish Multicenter Cohort Study
Completed NCT02846129 - Incidence of Complications Associated With Anesthesia in Multiple Gestation Undergoing Cesarean Delivery N/A
Completed NCT00799955 - Comparing 2 Types of Pain Relief After Cesarean Delivery: Spinal Morphine and TAP Block N/A
Completed NCT03336541 - Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression Phase 4
Completed NCT04358757 - Immune and Physical Recovery Following Cesarean Delivery
Completed NCT01755026 - Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery Phase 4
Recruiting NCT03746678 - Patient-Centred Perioperative Mobile Application
Completed NCT03349151 - Postoperative Results of Early Versus On-demand Maternal Feeding After Cesarean Delivery N/A
Completed NCT03729076 - Crystalloid Versus Colloid Rapid Co-load for Cesarean Delivery Under Spinal Anesthesia N/A
Completed NCT04799587 - Accupressure of P6 to Reduce Nausea During Cesarean Section N/A
Not yet recruiting NCT05758012 - Carbetocin Compared To Oxytocin During Cesarean Delivery
Completed NCT03781388 - ED90 for Hyperbaric Bupivacaine in Super Obese Parturients Phase 4
Completed NCT04349215 - Validation of the Chinese ObsQoR-11
Completed NCT04812223 - Timing of Umbilical Cord Clamping in Term Cesarean Deliveries N/A
Recruiting NCT05279703 - Epinephrine Infusion for Prophylaxis Against Maternal Hypotension During Cesarean Delivery Phase 4
Completed NCT01550640 - Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia N/A
Completed NCT00884026 - Can Augmentation Index (AIx) be Used to Predict Hypotension After Spinal Anesthesia? N/A